SS-OCT system is successful in evaluating macular choroidal thickness

Article

A study featured in Investigative Ophthalmology and Visual Science has demonstrated the accuracy of the swep-source optical coherence tomography (SS-OCT) system in evaluating choroidal thickness.

A study featured in Investigative Ophthalmology and Visual Science has demonstrated the accuracy of the swep-source optical coherence tomography (SS-OCT) system in evaluating choroidal thickness.

Dr Akitaka Tsujikawa et al., Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Japan, studied the macular area of 31 eyes from 31 healthy partcipants. Scans were completed in 0.8 seconds with an SS-OCT prototype system. The system’s light source is a tunable laser operating at 100,00 Hz.

The choroidal thickness map of the macular area was obtained by manual segmentation and was assessed in 10 participants by two observers.

It was found that the system enabled the visualization of the fine structure of the choroid and the retina. The mean macular volume and choroidal thickness were 191.5 ± 74.2 μm and 5.411 ± 2.097 mm3, respectively.

The results also demonstrated the intraclass correlation coefficient in mean choroidal thickness was between 0.945 and 0.980 in each area, meaning the measurements recorded the two observers were significantly identical.

Macular choroidal thickness was strongly linked to axial length after adjustment for age and age after adjustment for axial length. The SS-OCT at 1 μm provides a significantly accurate method for the measurement of choroidal thickness.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.